Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:9 Number:22 ISSN#:2564-2537
RCT
ACE Report #10376
Ace Report Cover Cannabis

Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo


How to Cite

OrthoEvidence. Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo. ACE Report. 2018;7(9):22. Available from: https://myorthoevidence.com/AceReport/Report/10376

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study

Clin Gastroenterol Hepatol. 2017 Jul;15(7):1079-1086.e4. doi: 10.1016/j.cgh.2016.09.147

Contributing Authors: M de Vries DCM van Rijckevorsel KCP Vissers OHG Wilder-Smith H van Goor Group Pain and Nociception Neuroscience Research

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

65 patients with chronic abdominal pain following surgery or due to chronic pancreatitis were randomized to receive delta-9-tetrahydrocannabinol (THC) or placebo for 50-52 days. The primary outcome was pain relief, as measured by a visual analogue scale (VAS). Secondary outcomes included other measures of pain, depression, anxiety, quality of life, treatment satisfaction, appetite, alertness, mood...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.